Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 to 64

Breaking up sedentary time to improve glucose control in people at risk for type 2 diabetes

Official title: Breaking up Sedentary Time to Improve Glucose Control in a Population at Risk for Developing Type 2 Diabetes

Run by University of Colorado, Denver · NCT05041491 · Data updated 2026-11-12

This study tests if taking short breaks for 5-minute physical activities can help people at risk for type 2 diabetes control their blood sugar better than just doing longer workouts.

More Pre Diabetes trials

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment66 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations1 site (Aurora, Colorado)
StatusRecruiting
StartedNovember 30, 2021
Main results expectedMay 15, 2026
Study endsNovember 30, 2026
Registry record updatedJuly 29, 2025
Trial IDNCT05041491 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-64 with pre-diabetes and high sedentary behavior, as defined by specific glucose levels and physical activity metrics.

Probably not a fit

Patients who are already highly active or have significant comorbidities that limit physical activity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of interrupting prolonged sedentary behavior with short bouts of physical activity on glucose control in individuals at risk for developing type 2 diabetes. Participants will engage in brief, 5-minute physical activity sessions throughout the day, rather than traditional longer exercise sessions. The goal is to determine if this novel approach can lead to better glycemic outcomes compared to standard physical activity recommendations. The study will include individuals who meet specific criteria for pre-diabetes and sedentary behavior.

Why it matters

Potential benefit: If successful, this approach could significantly improve glucose control and reduce the risk of developing type 2 diabetes in at-risk populations.

How similar studies have gone: Preliminary data suggest that breaking up sedentary time may improve glycemia, indicating potential success for this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male and female
* BMI of 18.5-40 kg/m2 and weight stable over the previous 6 months.
* Age, 18-64 years old.
* Fasting glucose of 100-125 mg/dL or fasting HbA1c of 5.7-6.4%, or 2h OGTT blood glucose of 140-199mg/dL based on the American Diabetes Association criteria for pre-diabetes. Fasting glucose, HbA1c and OGTT results ordered by the participant's provider within 3-months of the screening visit will be accepted, provided they fall within the measurement of error range established by the institution's lab standards. Additionally, consistent use of Metformin (1 year) to prevent prediabetes from developing diabetes will be accepted.
* Less than 150 minutes of moderate-to-vigorous physical activity (MVPA) per week and more than 6 hours of sitting time per day, as self-reported by the volunteers using the International Physical Activity Questionnaire (IPAQ).
* Less than 6500 of steps per day as measured by a pedometer over 5 days (at least 1 weekend day).
* Passing medical and physical screening, and analysis of blood and urine screening samples.
* Low-moderate caffeine use (\<3 cups/day).
* Agree to refrain from any other structured exercise than the physical activity prescribed in each arm of the study.
* Agree to eat control diets for 3 days before and during the Clinical and Translational Research Center (CTRC) visits;
* Agree to refrain from taking any over-the-counter (including nonsteroidal anti-inflammatory drugs) or prescribed medication (apart from oral contraceptives) for 3 days prior to the inpatient CTRC visits;
* Agree to wear a Fitbit® activity monitor and upload data on the website on a daily basis for the whole duration of the study.
* Agree to follow the physical activity interventions and to be randomly assigned to one of the two arms of the study.
* Agree to complete all the study procedures.

Exclusion Criteria:

* Pregnancy, breast-feeding or post-menopause for women.
* Being considered unsafe to participate as determined by the study physician.
* Ever having a history of systemic, psychiatric, neurological disease, or drug and alcohol abuse.
* History of cardiovascular disease, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases, dyslipidemia or any other medical condition affecting weight or lipid metabolism.
* Being positive for human immunodeficiency virus or hepatitis B or C.
* Taking medications affecting weight, triglycerides, energy intake/energy expenditure, or sleep in the last 3 months.
* Having abnormal blood chemistry and/or hematology as deemed significant by the study physician.
* Being a smoker or having been a smoker in the 3 months prior to their screening visit.
* Having donated over 400 mL of blood within 3 months (90 days) of screening for the study;
* Working night shifts within 1 month of and throughout the study.
* Not completing the trial days of BREAK and ONE during the screening period to assess the willingness and ability of the participant to perform each of the interventions.

Where it's running

  • University of Colorado Anschutz Medical Campus
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.